Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 23, 2022 10:54 ET | Source: Antisense Therapeutics Limited

Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets

World first study utilizing Somalogic SomaScan® assay# to assess up to 7,000 plasma proteins in Long COVID-19 patients has elucidated novel blood markers as potential diagnostic and therapeutic...
August 22, 2022 07:40 ET | Source: Antisense Therapeutics Limited

Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets

World first study utilizing Somalogic SomaScan® assay# to assess up to 7,000 plasma proteins in Long COVID-19 patients has elucidated novel blood markers as potential diagnostic and therapeutic...
June 22, 2022 09:15 ET | Source: Antisense Therapeutics Limited

New Muscle Disease Indication for ATL1102 – Limb Girdle Muscular Dystrophy R2

LGMDR2, also referred to as dysferlinopathy, is a rare genetic muscle disease caused by mutations in the dysferlin gene (DYSF)Animal study conducted at MCRI in collaboration with Jain Foundation in...
March 09, 2022 15:01 ET | Source: Antisense Therapeutics Limited

Antisense Therapeutics to present poster at world’s largest NMD conference

New York, NY, March 09, 2022 (GLOBE NEWSWIRE) -- Antisense Therapeutics Limited [ASX: ANP | US OTC: ATHJY | FSE: AWY] will deliver a virtual presentation on its antisense drug at the Muscular...